An arterial spin labeling-based radiomics signature and machine learning for the prediction and detection of various stages of kidney damage due to diabetes.

Journal: Frontiers in endocrinology
PMID:

Abstract

OBJECTIVE: The aim of this study was to assess the predictive capabilities of a radiomics signature obtained from arterial spin labeling (ASL) imaging in forecasting and detecting stages of kidney damage in patients with diabetes mellitus (DM), as well as to analyze the correlation between texture feature parameters and biological clinical indicators. Additionally, this study seeks to identify the imaging risk factors associated with early renal injury in diabetic patients, with the ultimate goal of offering novel insights for predicting and diagnosing early renal injury and its progression in patients with DM.

Authors

  • Feier Ma
    National Health Commission (NHC) Key Laboratory of Hormones and Development, Chu Hsien-I Memorial Hospital and Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China.
  • Xian Shao
    NHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, 300134, China.
  • Yuling Zhang
    Department of Radiology, Tianjin First Central Hospital, Tianjin, China.
  • Jinlao Li
    Ultrasound Diagnostic Center, The First Hospital of Jilin University, Jilin, China.
  • Qiuhong Li
    National Health Commission (NHC) Key Laboratory of Hormones and Development, Chu Hsien-I Memorial Hospital and Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China.
  • Haizhen Sun
    National Health Commission (NHC) Key Laboratory of Hormones and Development, Chu Hsien-I Memorial Hospital and Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China.
  • Tongdan Wang
    National Health Commission (NHC) Key Laboratory of Hormones and Development, Chu Hsien-I Memorial Hospital and Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China.
  • Hongyan Liu
    Department of Gastroenterology, The First Affiliated Hospital of Shandong First Medical University& Shandong Provincial Qianfoshan Hospital, Jinan, China.
  • Feiyu Zhao
    Respiratory and Critical Care Medicine Department, The Third Medical Center of the People's Liberation Army General Hospital, Beijing, China.
  • Lianqin Chen
    NHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, 300134, China.
  • Jiamian Chen
    National Health Commission (NHC) Key Laboratory of Hormones and Development, Chu Hsien-I Memorial Hospital and Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China.
  • Saijun Zhou
    National Health Commission (NHC) Key Laboratory of Hormones and Development, Chu Hsien-I Memorial Hospital and Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China.
  • Qian Ji
    Oriental Organ Transplant Center of Tianjin First Central Hospital, Tianjin, China.
  • Pei Yu
    School of Acu-Mox and Tuina, Chengdu University of Traditional Chinese Medicine, Chengdu, China.